Johnson & Johnson Vision Care, Inc., a global leader in eye health and a division of Johnson & Johnson MedTech, has introduced its newest product, ACUVUE OASYS MAX 1-DAY contact lenses and ACUVUE OASYS MAX 1-DAY MULTIFOCAL contact lenses for presbyopia.
CooperVision announced the launch of MyDay Energys daily disposable contact lenses to its product portfolio, with digital device use putting higher demands on the eyes than ever before. MyDay Energys, which was first included in the company's ground-breaking Biofinity Energys, is the first 1-day contact lens with a revolutionary single vision aspheric lens design.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 268
Published Date: Feb 13, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The major factors driving the growth of the market are growing prevalence of cataract disease, growing geriatric population, high demand for sunglasses, and others.
The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033.
High price of eyewear, presence of counterfeit products, and unavailability of eyewear in rural part are some of the major factors expected to hinder the growth of the market.
The market in Europe is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
The major players in the market are Johnson & Johnson Vision Care, Inc., EssilorLuxottica, CooperVision, Zeiss International, and more.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product type, distribution channel, end user, and by region.
The spectacles segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.